LAUSANNE, SWITZERLAND – February 1st, 2022 – Novigenix Co-founder and CTO Dr Sahar Hosseinian shares her successful path to founding Novigenix and entrepreneurship in an interview by Lausanne’s Life Science Hub Biopôle.
“I met two biologists who were hugely inspiring and had amazing data that leveraged the host response in cancer patients to save their lives. […] I found it incredible that we can take immune response data and turn it into information that helps patients.”
She presents Novigenix’s unique value proposition for a competitive market and shares her personal tips to successful entrepreneurship.
Read the full interview here.